Template:Nucleic acid inhibitors: Difference between revisions
Content deleted Content added
m r2.7.2) (Robot: Adding zh:Template: |
Innerstream (talk | contribs) No edit summary |
||
(41 intermediate revisions by 31 users not shown) | |||
Line 1: | Line 1: | ||
{{Navbox |
{{Navbox |
||
| name |
| name = Nucleic acid inhibitors |
||
| title |
| title = [[Antibiotics|Antibacterials]] that [[nucleic acid inhibitor|inhibit nucleic acid]] ([[ATC code J01#J01E|J01E]], [[ATC code J01#J01M|J01M]]) |
||
| state = {{{state<includeonly>|autocollapse</includeonly>}}} |
|||
| listclass = hlist |
|||
| listclass = hlist |
|||
| group1 = [[Antifolate]]s<br/>(inhibit bacterial<br/>[[purine metabolism|purine metabolism]],<br/>thereby inhibiting<br/>DNA and RNA<br/>synthesis) |
|||
| groupstyle = background:PowderBlue; |
|||
| list1 = {{Navbox|child |
|||
| group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitor]] |
|||
| group1 = [[Antifolate]]s<br />(inhibits<br/>[[purine metabolism]],<br />thereby inhibiting<br/> DNA and RNA synthesis) |
|||
| list1 = |
|||
| list1 = {{Navbox|child |
|||
* [[2,4-Diaminopyrimidine]] |
|||
| groupstyle = background:PowderBlue; |
|||
| group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitor]] |
|||
| list1 = |
|||
* ''[[2,4-Diaminopyrimidine]]'' |
|||
** [[Trimethoprim]]<sup>#</sup> |
|||
** [[Brodimoprim]] |
** [[Brodimoprim]] |
||
** [[Iclaprim]]<sup>†</sup> |
|||
** [[Ormetoprim]] |
|||
** [[Pyrimethamine]]<sup>#</sup> |
|||
** [[Tetroxoprim]] |
** [[Tetroxoprim]] |
||
** [[ |
** [[Trimethoprim]]<sup>#</sup> |
||
| group2 = [[Sulfonamide (medicine)|Sulfonamides]]<br />([[Dihydropteroate synthetase inhibitor|DHPS inhibitor]]) |
|||
| list2 = {{Navbox|child |
|||
| groupstyle = background-color: PowderBlue |
|||
| group1 = [[ |
| group1 = [[Sulfonamide (medicine)#Short-acting|Short-acting]] |
||
| list1 |
| list1 = |
||
* [[Sulfisomidine|Sulfaisodimidine]] |
* [[Sulfisomidine|Sulfaisodimidine]] |
||
* [[Sulfamethizole]] |
* [[Sulfamethizole]] |
||
* [[Sulfadimidine]] |
* [[Sulfadimidine]] |
||
* [[Sulfapyridine]] |
* [[Sulfapyridine]] ([[Sulfasalazine]]) |
||
* [[Sulfafurazole]] |
* [[Sulfafurazole]] ([[Acetyl sulfisoxazole]]) |
||
* [[Sulfanilamide]] |
* [[Sulfanilamide]] |
||
** [[Prontosil]] |
** [[Prontosil]] |
||
* [[Sulfathiazole]] |
* [[Sulfathiazole]] ([[Phthalylsulfathiazole]], [[Succinylsulfathiazole]]) |
||
* [[Sulfathiourea]] |
* [[Sulfathiourea]] |
||
| group2 = [[ |
| group2 = [[Sulfonamide (medicine)#Intermediate-acting|Intermediate-acting]] |
||
| list2 |
| list2 = |
||
* [[Sulfamethoxazole]] |
* [[Sulfamethoxazole]] |
||
* [[Sulfadiazine]]<sup>#</sup> |
* [[Sulfadiazine]]<sup>#</sup> |
||
* [[Sulfamoxole]] |
* [[Sulfamoxole]] |
||
| group3 = [[ |
| group3 = [[Sulfonamide (medicine)#Long-acting|Long-acting]] |
||
| list3 |
| list3 = |
||
* [[Sulfadimethoxine]] |
* [[Sulfadimethoxine]] |
||
* [[Sulfadoxine]] |
|||
* [[Sulfalene]] |
* [[Sulfalene]] |
||
* [[Sulfametomidine]] |
* [[Sulfametomidine]] |
||
Line 52: | Line 52: | ||
* [[Sulfamazone]] |
* [[Sulfamazone]] |
||
| group4 = Other/ungrouped |
|||
}} |
|||
| list4 = |
|||
* [[Mafenide]] |
|||
* [[Sulfacetamide]] |
|||
* [[Sulfaclozine]] |
|||
* [[Sulfadicramide]] |
|||
* [[Sulfaguanidine]] |
|||
* [[Sulfametrole]] |
|||
* [[Sulfanitran]] |
|||
}} |
|||
| group5 = Other/ungrouped |
|||
| list5 = |
|||
* ''[[sulfanilamide]]'' |
|||
** [[Sulfacetamide]] |
|||
** [[Sulfametrole]] |
|||
| |
| group3 = Combinations |
||
| list3 = |
|||
* [[Trimethoprim/sulfamethoxazole]]<sup>#</sup> |
* [[Trimethoprim/sulfamethoxazole]]<sup>#</sup> |
||
* [[Sulfadimethoxine#with ormetoprim|Ormetoprim/sulfadimethoxine]] |
|||
* [[Pyrimethamine/dapsone]] |
|||
* [[Pyrimethamine/sulfadoxine]] |
|||
}} |
|||
| group2 = [[Topoisomerase inhibitor|Topoisomerase<br/> inhibitors]]/<br />[[quinolones]]/<br />(inhibits<br/>[[DNA replication]]) |
|||
| list2 = {{Navbox|child |
|||
| groupstyle = background:PowderBlue; |
|||
| group4 = Other DHPS inhibitors |
|||
| group1 = [[Fluoroquinolone#1st_generation|1st g.]] |
|||
| list4 = |
|||
* [[Acediasulfone]] |
|||
* [[Dapsone]] |
|||
* [[Solasulfone]] |
|||
* [[Sulfoxone]] |
|||
}} |
|||
| group2 = [[Quinolone antibiotic|Quinolone]]s<br/>(inhibit bacterial<br/>[[Topoisomerase inhibitor|topoisomerase]]<br/>and/or [[DNA gyrase|DNA gyrase]],<br/>thereby inhibiting<br/>[[DNA replication]]) |
|||
| list2 = {{Navbox|child |
|||
| group1 = [[Quinolone antibiotic#First generation|1st generation]] |
|||
| list1 = |
|||
* [[Cinoxacin]]<sup>‡</sup> |
* [[Cinoxacin]]<sup>‡</sup> |
||
* [[Flumequine]] |
* [[Flumequine]]<sup>‡</sup> |
||
* [[Nalidixic acid]] |
* [[Nalidixic acid]]<sup>‡</sup> |
||
* [[Oxolinic acid]] |
* [[Oxolinic acid]]<sup>‡</sup> |
||
* [[Pipemidic acid]] |
* [[Pipemidic acid]]<sup>‡</sup> |
||
* [[Piromidic acid]] |
* [[Piromidic acid]]<sup>‡</sup> |
||
* [[Rosoxacin]] |
* [[Rosoxacin]]<sup>‡</sup> |
||
| group2 = [[Quinolone antibiotic|Fluoroquinolones]] |
|||
| group2 = [[Fluoroquinolone|Fluoro-<br />quinolone]]s |
|||
| list2 = {{Navbox|child |
|||
| groupstyle = background-color: PowderBlue |
|||
| |
| group1 = [[Quinolone antibiotic#Second generation|2nd generation]] |
||
| list1 = |
|||
| list2 = |
|||
* [[Ciprofloxacin]]<sup>#</sup> |
* [[Ciprofloxacin]]<sup>#</sup> |
||
* [[Ofloxacin]] |
|||
* [[Enoxacin]]<sup>‡</sup> |
* [[Enoxacin]]<sup>‡</sup> |
||
* [[Fleroxacin]]<sup>‡</sup> |
* [[Fleroxacin]]<sup>‡</sup> |
||
* [[Lomefloxacin]] |
* [[Lomefloxacin]]<sup>‡</sup> |
||
* [[Nadifloxacin]] |
* [[Nadifloxacin]]<sup>‡</sup>/[[Levonadifloxacin]]/[[Alalevonadifloxacin]] |
||
* [[Norfloxacin]]<sup>‡</sup> |
|||
* [[Ofloxacin]] |
|||
* [[Pefloxacin]]<sup>‡</sup> |
|||
* [[Norfloxacin]] |
|||
* [[Rufloxacin]]<sup>‡</sup> |
|||
* [[Pefloxacin]] |
|||
* [[Rufloxacin]] |
|||
| |
| group2 = [[Quinolone antibiotic#Third generation|3rd generation]] |
||
| list2 = |
|||
| list3 = |
|||
* [[Levofloxacin]]<sup>#</sup> |
|||
* [[Balofloxacin]] |
|||
* [[Balofloxacin]]<sup>‡</sup> |
|||
* [[Grepafloxacin]]<sup>‡</sup> |
* [[Grepafloxacin]]<sup>‡</sup> |
||
* [[Pazufloxacin]]<sup>‡</sup> |
|||
* [[Levofloxacin]] |
|||
* [[Pazufloxacin]] |
|||
* [[Sparfloxacin]]<sup>‡</sup> |
* [[Sparfloxacin]]<sup>‡</sup> |
||
* [[Temafloxacin]]<sup>‡</sup> |
* [[Temafloxacin]]<sup>‡</sup> |
||
* [[Tosufloxacin]] |
* [[Tosufloxacin]]<sup>‡</sup> |
||
| |
| group3 = [[Quinolone antibiotic#Fourth generation|4th generation]] |
||
| list3 = |
|||
| list4 = |
|||
* [[Besifloxacin]] |
* [[Besifloxacin]] |
||
* [[Delafloxacin]] |
|||
* [[Clinafloxacin]]<sup>†</sup> |
|||
* [[ |
* [[Gatifloxacin]] |
||
* [[Finafloxacin]] |
|||
* [[Gemifloxacin]] |
* [[Gemifloxacin]] |
||
* [[Moxifloxacin]] |
* [[Moxifloxacin]]<sup>#</sup> |
||
* [[ |
* [[Clinafloxacin]]<sup>†</sup> |
||
* [[Garenoxacin]]<sup>‡</sup> |
|||
* [[Sitafloxacin]] |
|||
* [[Prulifloxacin]]<sup>‡</sup> |
|||
* [[Sitafloxacin]]<sup>‡</sup> |
|||
* [[Trovafloxacin]]<sup>‡</sup>/[[Alatrofloxacin]]<sup>‡</sup> |
* [[Trovafloxacin]]<sup>‡</sup>/[[Alatrofloxacin]]<sup>‡</sup> |
||
* [[Prulifloxacin]] |
|||
| group5 = [[Fluoroquinolone#Veterinary_use|Vet.]] |
|||
| group4 = [[Quinolone antibiotic#Veterinary use|Veterinary]] |
|||
| list5 = |
|||
| list4 = |
|||
* [[Danofloxacin]] |
* [[Danofloxacin]] |
||
* [[Difloxacin]] |
* [[Difloxacin]] |
||
Line 127: | Line 144: | ||
* [[Orbifloxacin]] |
* [[Orbifloxacin]] |
||
* [[Pradofloxacin]] |
* [[Pradofloxacin]] |
||
* [[Sarafloxacin]] |
* [[Sarafloxacin]]<sup>‡</sup> |
||
}} |
|||
| group3 = Newer non-fluorinated |
|||
| group6 = Related ([[DNA gyrase|DG]]) |
|||
| list3 = |
|||
* [[Nemonoxacin]] |
|||
* [[Ozenoxacin]] |
|||
| group4 = Related ([[DNA gyrase|DG]]) |
|||
| list4 = |
|||
* [[Aminocoumarin]]s: [[Novobiocin]] |
* [[Aminocoumarin]]s: [[Novobiocin]] |
||
}} |
}} |
||
| group3 = [[Anaerobic organism|Anaerobic]] DNA<br />[[Nucleic acid inhibitor#DNA inhibitors|inhibitors]] |
|||
}} |
|||
| list3 = {{Navbox|child |
|||
| group1 = [[Nitroimidazole]] derivatives |
|||
| group3 = [[Anaerobic organism|Anaerobic]] DNA<br />[[Nucleic_acid_inhibitor#DNA_inhibitors|inhibitors]] |
|||
| list1 = |
|||
| list3 = {{Navbox|child |
|||
* [[Metronidazole]]<sup>#</sup> |
|||
| groupstyle = background-color: PowderBlue |
|||
* [[Ornidazole]] |
|||
* [[Secnidazole]] |
|||
| group1 = [[Nitroimidazole|Nitro-]] [[imidazole]] derivatives |
|||
| list1 = |
|||
* [[Metronidazole]]<sup>#</sup> |
|||
* [[Tinidazole]] |
* [[Tinidazole]] |
||
* [[Ornidazole]] |
|||
| group2 = [[Nitrofuran]] derivatives |
| group2 = [[Nitrofuran]] derivatives |
||
| list2 |
| list2 = |
||
* [[ |
* [[Furazolidone]]<sup>‡</sup> |
||
* [[Nifuroxazide]] |
|||
* [[Furazolidone]]<sup>‡</sup> |
|||
* [[Nifurtoinol]] |
* [[Nifurtoinol]] |
||
* [[Nifurzide]] |
|||
* [[Nitrofurantoin]]<sup>#</sup> |
|||
* [[Nitrofurazone]] |
|||
}} |
|||
| group4 = [[RNA]] synthesis |
|||
}} |
|||
| list4 = {{Navbox|child |
|||
| group1 = [[Rifamycin]]s/<br />[[RNA-dependent RNA polymerase|RNA polymerase]] |
|||
| group4 = [[RNA]] synthesis |
|||
| list1 = |
|||
| list4 = {{Navbox|child |
|||
* [[Rifampicin]]<sup>#</sup> |
|||
| groupstyle = background-color: PowderBlue |
|||
* [[Rifabutin]]<sup>#</sup> |
|||
* [[Rifapentine]]<sup>#</sup> |
|||
* [[Rifaximin]] |
|||
* [[Rifalazil]]<sup>§</sup> |
|||
| group2 = [[Lipiarmycin]]s |
|||
| group1 = [[Rifamycin]]s/<br/>[[RNA-dependent RNA polymerase|RNA polymerase]] |
|||
| list2 = |
|||
* [[ |
* [[Fidaxomicin]] |
||
* [[Rifabutin]] |
|||
* [[Rifapentine]] |
|||
* [[Rifaximin]] |
|||
}} |
|||
| belowstyle = background: transparent; padding: 0px; |
|||
}} |
|||
| below = {{PharmNavFootnote}} |
|||
| belowstyle = background: transparent; padding: 0px; |
|||
| below = {{PharmNavFootnote}}{{Bacteria navs}} |
|||
}}<noinclude> |
}}<noinclude> |
||
{{collapsible option}} |
|||
[[Category:Nucleic acid inhibitor antibiotics]] |
|||
[[Category: |
[[Category:Drug templates by ATC]] |
||
[[Category:Bactericides|*]] |
|||
[[zh:Template: |
|||
</noinclude> |
</noinclude> |
Latest revision as of 17:15, 4 May 2024
This template's initial visibility currently defaults to autocollapse
, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state=
parameter may be used:
{{Nucleic acid inhibitors|state=collapsed}}
will show the template collapsed, i.e. hidden apart from its title bar.{{Nucleic acid inhibitors|state=expanded}}
will show the template expanded, i.e. fully visible.